Let's talk about mucormycosis emergency with COVID-19: Invest in future
Despite recent breakthroughs in the detection and treatment during the COVID-19 pandemic, mucormycosis is a serious infection with a high death rate. It is a filamentous fungal infection from the zygomycetes class of order mucorales. It is a fatal fungal infection with a 50% or higher overall fatali...
Main Authors: | Kamlesh Malik, Jyoti Arora, Parvin K Yadav, Kusum K Rohilla |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=3;spage=825;epage=827;aulast=Malik |
Similar Items
-
Role of Inflammatory Markers as Prognostic Indicators in Treatment of Mucormycosis
by: Pruthvi RajS, et al.
Published: (2023-03-01) -
Role of Inflammatory Markers as Prognostic Indicators in Treatment of Mucormycosis
by: Pruthvi RajS, et al.
Published: (2023-03-01) -
Expert opinion – Rhino-orbital-cerebral mucormycosis
by: Mohan Rajan, et al.
Published: (2021-01-01) -
Management of post-COVID mucormycosis at a tertiary care center in Northern India
by: Lav Pathak, et al.
Published: (2023-01-01) -
Rhino-orbito-cerebral mucormycosis in COVID 19 patients: Understanding the pathophysiology
by: Deepsekhar Das, et al.
Published: (2021-01-01)